What’s Going On With Microvision (MVIS) Shares

Microvision Inc (NASDAQ: MVIS) shares are trading higher by 20.6% to $6.43 Tuesday, despite a lack of company-specific news.

Microvision Inc (NASDAQ:MVIS) shares are trading higher by 20.6% to $6.43 Tuesday, despite a lack of company-specific news. MVIS stock is rising on heavy volume Tuesday morning with 2.6 million shares traded, nearly matching the trailing 100-day trailing volume of 2.9 million shares.

The increase in share price Tuesday is taking place as the stock trends across social media platforms. Microvision shares may also be experiencing a short squeeze. MVIS has a total share float of 175.434 million, of which 47.64 million shares are sold short, representing 27.16% of shares sold short.

See Also: SEC Accuses Coinbase Of ‘Acting As Unregistered Broker’

Microvision is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications.

According to data from Benzinga Pro, MVIS has a 52-week high of $5.96 and a 52-week low of $1.82.

Total
0
Shares
Related Posts
Read More

Delta Air Lines Reports Q4 Results, Joins United Airlines, American Airlines And Other Big Stocks Moving Lower On Friday

U.S. stocks traded mostly lower, with the Dow Jones index falling around 150 points on Friday. Shares of Delta Air Lines, Inc. (NYSE: DAL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued guidance.

AAL

Read More

Small-Cap Firm Century Therapeutics’ Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.

IPSC